aspirin has been researched along with Cognition Disorders in 54 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 973 patients aged≥75 years with atrial fibrillation were recruited from primary care and randomly assigned to warfarin (n=488; target international normalized ratio, 2-3) or aspirin (n=485; 75 mg/d)." | 9.19 | Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study). ( Fitzmaurice, D; Fletcher, K; Hobbs, FD; Lip, GY; Mant, J; Mavaddat, N; Roalfe, A, 2014) |
| "This paper describes the rationale and design of the ENVIS-ion Study, which aims to determine whether low-dose aspirin reduces the development of white matter hyper-intense (WMH) lesions and silent brain infarction (SBI)." | 9.16 | Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion). ( Abhayaratna, WP; Budge, MM; Essex, R; Janke, A; Kam, A; Reid, CM; Storey, E; Tonkin, A; Wang, JJ; Wong, TY; Woods, R, 2012) |
| "To examine the association of cognitive impairment with platelet activation and reactive oxygen species and total homocysteine levels; and to assess the biochemical efficacy of treatment with aspirin and vitamin supplements in people at high risk of dementia." | 9.10 | Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. ( Clarke, R; Harrison, G; Richards, S, 2003) |
| "This paper will examine how cerebral perfusion deficits in cocaine abusers may be a target for pharmacotherapy." | 8.80 | Pharmacotherapy of cerebral ischemia in cocaine dependence. ( Kosten, TR, 1998) |
| " The authors--in view of the increased neuroinflammatory reaction frequently observed during normal brain ageing--suggest the long-term use of "fatty aspirin", an association of DHA and/or NPD1 and aspirin (or nitroaspirin), to postpone, or prevent, the structural neurodegeneration of the brain." | 5.35 | Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type? ( Bria, P; Di Gioia, A; Pomponi, M; Pomponi, MF, 2008) |
| "A total of 973 patients aged≥75 years with atrial fibrillation were recruited from primary care and randomly assigned to warfarin (n=488; target international normalized ratio, 2-3) or aspirin (n=485; 75 mg/d)." | 5.19 | Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study). ( Fitzmaurice, D; Fletcher, K; Hobbs, FD; Lip, GY; Mant, J; Mavaddat, N; Roalfe, A, 2014) |
| "This paper describes the rationale and design of the ENVIS-ion Study, which aims to determine whether low-dose aspirin reduces the development of white matter hyper-intense (WMH) lesions and silent brain infarction (SBI)." | 5.16 | Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion). ( Abhayaratna, WP; Budge, MM; Essex, R; Janke, A; Kam, A; Reid, CM; Storey, E; Tonkin, A; Wang, JJ; Wong, TY; Woods, R, 2012) |
| "Subjects consisted of 2312 men and women aged 50 to 80 years participating in the Aspirin for Asymptomatic Atherosclerosis Trial, all of whom were free of symptomatic cardiovascular disease at baseline." | 5.14 | Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. ( Deary, IJ; Fowkes, FG; Lowe, GD; Marioni, RE; Murray, GD; Price, JF; Rumley, A; Stewart, MC, 2009) |
| "3350 men and women aged over 50 participating in the aspirin for asymptomatic atherosclerosis trial." | 5.13 | Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. ( Butcher, I; Deary, IJ; Fowkes, FG; Murray, GD; Price, JF; Sandercock, P; Stewart, MC, 2008) |
| "To examine the association of cognitive impairment with platelet activation and reactive oxygen species and total homocysteine levels; and to assess the biochemical efficacy of treatment with aspirin and vitamin supplements in people at high risk of dementia." | 5.10 | Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. ( Clarke, R; Harrison, G; Richards, S, 2003) |
| "To investigate whether low-dose aspirin (<300 mg/d) can influence the onset of cognitive impairment or dementia in observational studies and improve cognitive test scores in randomized controlled trials (RCTs) in participants without dementia." | 4.95 | Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis. ( Carvalho, AF; Lin, PY; Maggi, S; Muller, C; Schofield, P; Solmi, M; Stubbs, B; Thompson, T; Tseng, PT; Veronese, N, 2017) |
| "This paper will examine how cerebral perfusion deficits in cocaine abusers may be a target for pharmacotherapy." | 4.80 | Pharmacotherapy of cerebral ischemia in cocaine dependence. ( Kosten, TR, 1998) |
| " Data were analysed from three community-dwelling populations of older persons (>50 years) in central Scotland: the Aspirin for Asymptomatic Atherosclerosis (AAA) Trial (n = 2,091), the Edinburgh Type 2 Diabetes Study (ET2DS, n = 1,066), and the Lothian Birth Cohort 1936 (LBC1936, n = 1,091)." | 3.77 | Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts. ( Deary, IJ; Fowkes, FG; Gow, AJ; Harris, SE; Houlihan, LM; Lowe, GD; Luciano, M; Marioni, RE; Murray, GD; Price, JF; Rumley, A; Stewart, MC; Strachan, MW, 2011) |
| "Recent data indicate that patients with vascular dementia (VaD) show a cholinergic deficit." | 2.71 | Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study. ( Antonello, RM; Bava, A; Cazzato, G; Griggio, S; Moretti, R; Torre, P; Ukmar, M, 2004) |
| "For patients with a diagnosis of vascular dementia there is evidence that aspirin is widely prescribed - in one study, completed by geriatricians and psychiatrists in the UK, 80% of patients with cognitive impairment (with vascular risk factors) were prescribed aspirin." | 2.41 | Aspirin for vascular dementia. ( Orrell, M; Rands, G; Spector, A; Williams, PS, 2000) |
| "For patients with a diagnosis of vascular dementia there is evidence that aspirin is widely prescribed - in one study, completed by geriatricians and psychiatrists in the UK, 80% of patients with cognitive impairment (with vascular risk factors) were prescribed aspirin." | 2.41 | Aspirin for vascular dementia. ( Orrel, M; Rands, G; Spector, A; Williams, PS, 2000) |
| " A number of secondary analyses were performed, including lobe-specific analyses, subgroup analyses based on participants' overall risk of cerebrovascular disease, and a dose-response relationship analysis." | 1.46 | Chronic Use of Aspirin and Total White Matter Lesion Volume: Results from the Women's Health Initiative Memory Study of Magnetic Resonance Imaging Study. ( Ammann, E; Espeland, MA; Holcombe, A; Kelley, BJ; Manson, JE; Robinson, J; Wallace, R, 2017) |
| " The authors--in view of the increased neuroinflammatory reaction frequently observed during normal brain ageing--suggest the long-term use of "fatty aspirin", an association of DHA and/or NPD1 and aspirin (or nitroaspirin), to postpone, or prevent, the structural neurodegeneration of the brain." | 1.35 | Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type? ( Bria, P; Di Gioia, A; Pomponi, M; Pomponi, MF, 2008) |
| "None experienced strokes or transient ischemic attacks." | 1.35 | Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device. ( Dia, M; Gallagher, C; Silver, MA; Slaughter, MS; Sobieski, MA, 2008) |
| " Overall, we found no relation between regular aspirin use and cognitive decline, but long-term use of ibuprofen may be related to decreased rates of cognitive decline in older persons." | 1.35 | Anti-inflammatory agents and cognitive decline in a bi-racial population. ( Bennett, DA; Bienias, JL; Evans, DA; Grodstein, F; Skarupski, KA; Wilson, RS, 2008) |
| "Colitis was induced in rats by an enema containing 2,4,6-trinitrobenzen sulfonic acid." | 1.32 | Decrease in non-selective, non-sustained attention induced by a chronic visceral inflammatory state as a new pain evaluation in rats. ( Ardid, D; Eschalier, A; Etienne, M; Jourdan, D; Millecamps, M, 2004) |
| "Stroke is highly prevalent in long-term care." | 1.31 | Clinical correlates and drug treatment of residents with stroke in long-term care. ( Lapane, KL; Quilliam, BJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (9.26) | 18.7374 |
| 1990's | 4 (7.41) | 18.2507 |
| 2000's | 21 (38.89) | 29.6817 |
| 2010's | 23 (42.59) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, SW | 1 |
| Kuo, YH | 1 |
| Liao, KF | 1 |
| Veronese, N | 1 |
| Stubbs, B | 1 |
| Maggi, S | 1 |
| Thompson, T | 1 |
| Schofield, P | 1 |
| Muller, C | 1 |
| Tseng, PT | 1 |
| Lin, PY | 1 |
| Carvalho, AF | 1 |
| Solmi, M | 1 |
| Holcombe, A | 1 |
| Ammann, E | 1 |
| Espeland, MA | 1 |
| Kelley, BJ | 2 |
| Manson, JE | 1 |
| Wallace, R | 1 |
| Robinson, J | 1 |
| Li, S | 1 |
| Zhang, X | 1 |
| Fang, Q | 1 |
| Zhou, J | 1 |
| Zhang, M | 1 |
| Wang, H | 1 |
| Chen, Y | 1 |
| Xu, B | 1 |
| Wu, Y | 1 |
| Qian, L | 1 |
| Xu, Y | 1 |
| Douiri, A | 1 |
| McKevitt, C | 1 |
| Emmett, ES | 1 |
| Rudd, AG | 1 |
| Wolfe, CD | 1 |
| Mavaddat, N | 2 |
| Roalfe, A | 2 |
| Fletcher, K | 2 |
| Lip, GY | 2 |
| Hobbs, FD | 2 |
| Fitzmaurice, D | 2 |
| Mant, J | 2 |
| Zito, S | 1 |
| Lattanzio, F | 1 |
| Di Nisio, M | 1 |
| Selim, MH | 1 |
| Molina, CA | 1 |
| Falcone, GJ | 1 |
| Rosand, J | 1 |
| Al-Shahi Salman, R | 1 |
| Dennis, MS | 1 |
| McClure, LA | 2 |
| Unverzagt, FW | 1 |
| Kissela, B | 1 |
| Kleindorfer, D | 1 |
| Howard, G | 2 |
| Wadley, VG | 1 |
| Wang, LP | 1 |
| Zhang, XY | 1 |
| Liu, N | 1 |
| Ma, ZZ | 1 |
| Fang, DS | 1 |
| Price, JF | 3 |
| Stewart, MC | 3 |
| Deary, IJ | 3 |
| Murray, GD | 3 |
| Sandercock, P | 1 |
| Butcher, I | 1 |
| Fowkes, FG | 3 |
| Eikelboom, JW | 1 |
| O'Donnell, M | 1 |
| Pomponi, M | 1 |
| Di Gioia, A | 1 |
| Bria, P | 1 |
| Pomponi, MF | 1 |
| Slaughter, MS | 1 |
| Sobieski, MA | 1 |
| Gallagher, C | 1 |
| Dia, M | 1 |
| Silver, MA | 1 |
| Boncoraglio, GB | 1 |
| Bodini, A | 1 |
| Brambilla, C | 1 |
| Corsini, E | 1 |
| Carriero, MR | 1 |
| Parati, EA | 1 |
| Puccio, D | 1 |
| Novo, G | 1 |
| Baiamonte, V | 1 |
| Nuccio, A | 1 |
| Fazio, G | 1 |
| Corrado, E | 1 |
| Coppola, G | 1 |
| Muratori, I | 1 |
| Vernuccio, L | 1 |
| Novo, S | 1 |
| Marioni, RE | 2 |
| Lowe, GD | 2 |
| Rumley, A | 2 |
| Wang, T | 1 |
| Fu, FH | 1 |
| Han, B | 1 |
| Zhang, LM | 1 |
| Zhang, XM | 1 |
| Almeida, OP | 1 |
| Alfonso, H | 1 |
| Jamrozik, K | 1 |
| Hankey, GJ | 1 |
| Flicker, L | 1 |
| He, L | 1 |
| Chen, X | 1 |
| Zhou, M | 1 |
| Zhang, D | 1 |
| Yang, J | 1 |
| Yang, M | 1 |
| Zhou, D | 1 |
| Strachan, MW | 1 |
| Luciano, M | 1 |
| Houlihan, LM | 1 |
| Gow, AJ | 1 |
| Harris, SE | 1 |
| Benavente, OR | 1 |
| White, CL | 1 |
| Pearce, L | 1 |
| Pergola, P | 1 |
| Roldan, A | 1 |
| Benavente, MF | 1 |
| Coffey, C | 1 |
| Szychowski, JM | 1 |
| Conwit, R | 1 |
| Heberling, PA | 1 |
| Bazan, C | 1 |
| Vidal-Pergola, G | 1 |
| Talbert, R | 1 |
| Hart, RG | 1 |
| Acelajado, MC | 1 |
| Oparil, S | 1 |
| Reid, CM | 1 |
| Storey, E | 1 |
| Wong, TY | 1 |
| Woods, R | 1 |
| Tonkin, A | 1 |
| Wang, JJ | 1 |
| Kam, A | 1 |
| Janke, A | 1 |
| Essex, R | 1 |
| Abhayaratna, WP | 1 |
| Budge, MM | 1 |
| Zhang, SJ | 1 |
| Xue, ZY | 1 |
| Colloca, G | 1 |
| Tosato, M | 1 |
| Vetrano, DL | 1 |
| Topinkova, E | 1 |
| Fialova, D | 1 |
| Gindin, J | 1 |
| van der Roest, HG | 1 |
| Landi, F | 1 |
| Liperoti, R | 1 |
| Bernabei, R | 1 |
| Onder, G | 1 |
| Lance, EI | 1 |
| Sreenivasan, AK | 1 |
| Zabel, TA | 1 |
| Kossoff, EH | 1 |
| Comi, AM | 1 |
| Holinski, S | 1 |
| Claus, B | 1 |
| Barajas, T | 1 |
| Neumann, K | 1 |
| Uebelhack, R | 1 |
| Konertz, W | 1 |
| Brown, AF | 1 |
| Mangione, CM | 1 |
| Saliba, D | 1 |
| Sarkisian, CA | 1 |
| Kang, JH | 2 |
| Grodstein, F | 3 |
| Clarke, R | 1 |
| Harrison, G | 1 |
| Richards, S | 1 |
| Bellelli, G | 1 |
| Trabucchi, M | 1 |
| Millecamps, M | 1 |
| Etienne, M | 1 |
| Jourdan, D | 1 |
| Eschalier, A | 1 |
| Ardid, D | 1 |
| Moretti, R | 1 |
| Torre, P | 1 |
| Antonello, RM | 1 |
| Cazzato, G | 1 |
| Griggio, S | 1 |
| Ukmar, M | 1 |
| Bava, A | 1 |
| McLaurin, EY | 1 |
| Holliday, SL | 1 |
| Williams, P | 1 |
| Brey, RL | 1 |
| Cook, N | 1 |
| Manson, J | 1 |
| Buring, JE | 1 |
| Whalley, LJ | 1 |
| Mowat, DH | 1 |
| Prettyman, RJ | 1 |
| Skarupski, KA | 1 |
| Bienias, JL | 1 |
| Wilson, RS | 1 |
| Bennett, DA | 1 |
| Evans, DA | 1 |
| Porter, D | 1 |
| Rockwood, K | 1 |
| Ebly, E | 1 |
| Hachinski, V | 1 |
| Hogan, D | 1 |
| Richards, M | 1 |
| Meade, TW | 1 |
| Peart, S | 1 |
| Brennan, PJ | 1 |
| Mann, AH | 1 |
| Kosten, TR | 1 |
| Williams, PS | 2 |
| Spector, A | 2 |
| Orrell, M | 1 |
| Rands, G | 2 |
| Orrel, M | 1 |
| Quilliam, BJ | 1 |
| Lapane, KL | 1 |
| May, FE | 1 |
| Moore, MT | 1 |
| Stewart, RB | 1 |
| Hale, WE | 1 |
| de Groen, PC | 1 |
| Gogoll, L | 1 |
| Bentsen, P | 1 |
| Hochrein, H | 1 |
| Skiendzielewski, JJ | 1 |
| Parrish, G | 1 |
| Harrington, TM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Secondary Prevention of Small Subcortical Strokes (SPS3) Trial[NCT00059306] | Phase 3 | 3,020 participants (Actual) | Interventional | 2003-02-28 | Completed | ||
| TEC4Home Stroke - Assessing the Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA Patients. Pilot Study at Vancouver Stroke Program in Collaboration With TEC4Home Heart Failure Team[NCT03712033] | 50 participants (Actual) | Observational | 2018-03-01 | Completed | |||
| Aspirin in Reducing Events in the Elderly[NCT01038583] | 19,114 participants (Actual) | Observational | 2010-01-31 | Active, not recruiting | |||
| Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study[NCT01480804] | 48 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study[NCT01486290] | 52 participants (Actual) | Interventional | 2007-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for aspirin and Cognition Disorders
| Article | Year |
|---|---|
Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cognition; Cognition Disorders; Dementia; Humans; | 2017 |
Pharmacotherapy of cerebral ischemia in cocaine dependence.
Topics: Aspirin; Brain; Brain Ischemia; Cerebrovascular Circulation; Cocaine; Cocaine-Related Disorders; Cog | 1998 |
Aspirin for vascular dementia.
Topics: Aspirin; Cognition Disorders; Dementia, Vascular; Humans | 2000 |
Aspirin for vascular dementia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cognition Disorders; Dementia, Vascular; Humans; R | 2000 |
14 trials available for aspirin and Cognition Disorders
| Article | Year |
|---|---|
Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
Topics: Aged; Aspirin; Brain; China; Cognition; Cognition Disorders; Executive Function; Female; Ginkgo bilo | 2017 |
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
Topics: Aged; Aged, 80 and over; Aging; Anticoagulants; Aspirin; Atrial Fibrillation; Cognition Disorders; F | 2014 |
Comparison of integrated traditional Chinese and western medicine therapy on vascular cognitive impairment with no dementia.
Topics: Aged; Aspirin; Cerebellum; Cognition Disorders; Dementia; Drugs, Chinese Herbal; Female; Ginkgo bilo | 2015 |
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial.
Topics: Aged; Aspirin; Atherosclerosis; Cognition Disorders; Double-Blind Method; Drug Administration Schedu | 2008 |
Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.
Topics: Aspirin; Atherosclerosis; Biomarkers; Blood Viscosity; C-Reactive Protein; Cognition Disorders; Exec | 2009 |
Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study.
Topics: Activities of Daily Living; Aged; Aspirin; Brain Ischemia; Cognition Disorders; Double-Blind Method; | 2011 |
The Secondary Prevention of Small Subcortical Strokes (SPS3) study.
Topics: Antihypertensive Agents; Aspirin; Clopidogrel; Cognition Disorders; Humans; Hypertension; Magnetic R | 2011 |
The Secondary Prevention of Small Subcortical Strokes (SPS3) study.
Topics: Antihypertensive Agents; Aspirin; Clopidogrel; Cognition Disorders; Humans; Hypertension; Magnetic R | 2011 |
The Secondary Prevention of Small Subcortical Strokes (SPS3) study.
Topics: Antihypertensive Agents; Aspirin; Clopidogrel; Cognition Disorders; Humans; Hypertension; Magnetic R | 2011 |
The Secondary Prevention of Small Subcortical Strokes (SPS3) study.
Topics: Antihypertensive Agents; Aspirin; Clopidogrel; Cognition Disorders; Humans; Hypertension; Magnetic R | 2011 |
Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion).
Topics: Aged; Aging; Aspirin; Australia; Brain Infarction; Cognition; Cognition Disorders; Double-Blind Meth | 2012 |
Effect of Western medicine therapy assisted by Ginkgo biloba tablet on vascular cognitive impairment of none dementia.
Topics: Aged; Aspirin; Blood Flow Velocity; Cardiovascular Agents; Cerebrovascular Disorders; Cognition Diso | 2012 |
Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Dementia; Female; Folic Acid; Follow-Up Studi | 2003 |
Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study.
Topics: Aged; Aged, 80 and over; Aspirin; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Dement | 2004 |
Low dose aspirin and cognitive function in the women's health study cognitive cohort.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cognition Disorders; Cohort Studies; Health Status; Humans; | 2007 |
Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings.
Topics: Aged; Anticoagulants; Aspirin; Cardiovascular Diseases; Cognition; Cognition Disorders; Double-Blind | 1997 |
Darvon and Darvon-N.
Topics: Administration, Oral; Adolescent; Aspirin; Brain; Clinical Trials as Topic; Cognition Disorders; Cos | 1972 |
36 other studies available for aspirin and Cognition Disorders
| Article | Year |
|---|---|
Aspirin in people with dementia.
Topics: Aspirin; Cognition Disorders; Dementia; Humans | 2021 |
Chronic Use of Aspirin and Total White Matter Lesion Volume: Results from the Women's Health Initiative Memory Study of Magnetic Resonance Imaging Study.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Female; Humans; Leukoencephalopathies; Linear | 2017 |
Long-term effects of secondary prevention on cognitive function in stroke patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Cognition Disorders; Dipyridamole; Female | 2013 |
Letter by Zito et Al regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham atrial fibrillation treatment of the aged study)".
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cognition Disorders; Female; Fibrinolytic Agents; Huma | 2014 |
Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cognition Disorders; Female; Fibrinolytic Agents; Huma | 2014 |
Elderly and forgetful: is aspirin safe for you?
Topics: Aged, 80 and over; Aspirin; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Cognition Disorders; C | 2014 |
Aspirin should be discontinued after lobar intracerebral hemorrhage.
Topics: Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cognition Disorders; Comorbidity; Female; Humans; I | 2014 |
Antiplatelet therapy may be continued after intracerebral hemorrhage.
Topics: Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cognition Disorders; Comorbidity; Female; Humans; I | 2014 |
Regular aspirin use does not reduce risk of cognitive decline.
Topics: Aged; Aspirin; Cognition Disorders; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; St | 2015 |
Using aspirin to prevent cognitive decline.
Topics: Aspirin; Cognition Disorders; Humans; Neuroprotective Agents | 2008 |
Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type?
Topics: Alzheimer Disease; Animals; Antioxidants; Aspirin; Cognition Disorders; Dementia; Disease Models, An | 2008 |
Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
Topics: Adult; Aged; Aspirin; Brain Diseases, Metabolic; Cardiomyopathy, Dilated; Cause of Death; Cognition | 2008 |
Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease.
Topics: Aged; Aspirin; Cognition Disorders; Drug Resistance; Female; Follow-Up Studies; Hematologic Tests; H | 2009 |
Atrial fibrillation and mild cognitive impairment: what correlation?
Topics: Activities of Daily Living; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; | 2009 |
Long-term but not short-term aspirin treatment attenuates diabetes-associated learning and memory decline in mice.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2011 |
Aspirin use, depression, and cognitive impairment in later life: the health in men study.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Depression; Humans; Male | 2010 |
Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts.
Topics: Aged; Aging; Aspirin; Atherosclerosis; Cognition; Cognition Disorders; Cohort Studies; Cross-Section | 2011 |
Antiplatelet therapy for transient ischemic attack.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Clopidogrel; Cognition Disorders; | 2012 |
Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study.
Topics: Aged; Aged, 80 and over; Aspirin; Cholinesterase Inhibitors; Cognition Disorders; Cross-Sectional St | 2012 |
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Cognition Disorders; Elec | 2013 |
Cerebroprotective effect of preoperative dual antiplatelet therapy in patients undergoing coronary bypass surgery.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cardiopulmonary Bypass; Clopidogrel; Cognition; Cognition D | 2014 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Aging; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2003 |
The specificity of prescription patterns in secondary stroke prevention.
Topics: Accidental Falls; Anticoagulants; Aspirin; Cognition Disorders; Geriatric Assessment; Humans; Patien | 2004 |
Decrease in non-selective, non-sustained attention induced by a chronic visceral inflammatory state as a new pain evaluation in rats.
Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Attention; Behavior, Animal; | 2004 |
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Aspirin; Autoant | 2005 |
Aspirin and cognitive function.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cognition Disorders; Humans; Nootropic Agents | 2007 |
Too little, too late?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cognition Disorders; Humans; Nootropic Agents | 2007 |
Anti-inflammatory agents and cognitive decline in a bi-racial population.
Topics: Aged; Aged, 80 and over; Aging; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Black People; Chic | 2008 |
Drug induced confusional state.
Topics: Aged; Amitriptyline; Aspirin; Cognition Disorders; Confusion; Drug Interactions; Female; Humans; Sub | 1982 |
Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspirin; Cognition Disorders; Dementia; Diabetes Complic | 1997 |
Clinical correlates and drug treatment of residents with stroke in long-term care.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Databas | 2001 |
Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cognition Disorders; Fema | 1992 |
[Chronic poisoning due to salicylic acid compounds: frequently not diagnosed or treated wrong].
Topics: Acidosis; Aged; Aged, 80 and over; Alkalosis, Respiratory; Aspirin; Cognition Disorders; Confusion; | 1989 |
[Cerebral complications in chronic acetylsalicylic acid poisoning].
Topics: Aspirin; Chronic Disease; Cognition Disorders; Coma; Combined Modality Therapy; Consciousness Disord | 1989 |
Mental confusion in an elderly, chronically ill patient.
Topics: Aged; Aspirin; Chronic Disease; Cognition Disorders; Confusion; Emergencies; Female; Humans; Renal D | 1986 |